By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GlycoMimetics, Inc. 

14915 Broschart Road, Suite 200

Rockville   Maryland  20850  U.S.A.
Phone: 301-738-1166 Fax:




Company News
GlycoMimetics, Inc. (GLYC) Appoints Mark A. Goldberg, M.D. To Board of Directors 7/10/2014 11:21:54 AM
GlycoMimetics, Inc. (GLYC) Announces Agreement With FDA On Special Protocol Assessment For Phase 3 Clinical Trial Of Rivipansel (GMI-1070) 7/1/2014 11:00:36 AM
GlycoMimetics, Inc. (GLYC) Initiates First Clinical Trial Of GMI-1271 As Potential Treatment For Blood-Related Cancers 6/19/2014 9:19:26 AM
GlycoMimetics, Inc. (GLYC) To Present At Jefferies and Co. Healthcare Conference 5/28/2014 7:41:36 AM
GlycoMimetics, Inc. (GLYC) Gets A $15 Million Pay Day From Pfizer Inc. (PFE) 5/21/2014 6:25:03 AM
GlycoMimetics, Inc. (GLYC) Announces Presentation Of Rivipansel Data In Pediatric Patients At American Society Of Pediatric Hematology Oncology 27th Annual Meeting 5/15/2014 9:55:32 AM
GlycoMimetics, Inc. (GLYC) Reports First Quarter 2014 Results 5/8/2014 9:31:45 AM
GlycoMimetics, Inc. (GLYC) Release: Appoints Seasoned Business Development Executive Armand Girard As New Vice President, Corporate Development 4/23/2014 7:26:29 AM
GlycoMimetics, Inc. (GLYC) Announces Presentation Of Data On Rivipansel (GMI-1070) In Combination With Current FDA-Approved Treatment For Sickle Cell Disease 4/14/2014 9:45:15 AM
GlycoMimetics, Inc. (GLYC) Presents Data On Its E-Selectin Antagonist At American Association for Cancer Research Annual Meeting 2014 4/10/2014 7:47:06 AM